U.S. flag

An official website of the United States government

NM_023067.4(FOXL2):c.672_701dup (p.Ala225_Ala234dup) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Dec 5, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002512795.3

Allele description [Variation Report for NM_023067.4(FOXL2):c.672_701dup (p.Ala225_Ala234dup)]

NM_023067.4(FOXL2):c.672_701dup (p.Ala225_Ala234dup)

Gene:
FOXL2:forkhead box L2 [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
3q22.3
Genomic location:
Preferred name:
NM_023067.4(FOXL2):c.672_701dup (p.Ala225_Ala234dup)
HGVS:
  • NC_000003.12:g.138946030_138946059dup
  • NG_012454.1:g.6090_6119dup
  • NG_029796.1:g.3797_3826dup
  • NM_023067.4:c.672_701dupMANE SELECT
  • NP_075555.1:p.Ala225_Ala234dup
  • LRG_1295t1:c.672_701dup
  • LRG_1295:g.6090_6119dup
  • LRG_1295p1:p.Ala225_Ala234dup
  • NC_000003.11:g.138664863_138664864insGCGGCTGCAGCCGCAGCTGCTGCAGCCGCT
  • NC_000003.11:g.138664872_138664901dup
  • NM_023067.3:c.672_701dup30
  • p.(Ala225_Ala234dup)
  • p.[Ala225_Ala234dup]
Links:
OMIM: 605597.0002; dbSNP: rs387906321
NCBI 1000 Genomes Browser:
rs387906321
Molecular consequence:
  • NM_023067.4:c.672_701dup - inframe_insertion - [Sequence Ontology: SO:0001821]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002986554Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Dec 5, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

FOXL2 mutations in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome.

Wang J, Liu J, Zhang Q.

Mol Vis. 2007 Jan 26;13:108-13.

PubMed [citation]
PMID:
17277738
PMCID:
PMC2533039

Differential functional effects of novel mutations of the transcription factor FOXL2 in BPES patients.

Nallathambi J, Laissue P, Batista F, Benayoun BA, Lesaffre C, Moumné L, Pandaranayaka PE, Usha K, Krishnaswamy S, Sundaresan P, Veitia RA.

Hum Mutat. 2008 Aug;29(8):E123-31. doi: 10.1002/humu.20809.

PubMed [citation]
PMID:
18484667
See all PubMed Citations (3)

Details of each submission

From Invitae, SCV002986554.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This variant, c.672_701dup, results in the insertion of 10 amino acid(s) of the FOXL2 protein (p.Ala225_Ala234dup), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individuals with blepharophimosis (PMID: 17277738, 18484667). It has also been observed to segregate with disease in related individuals. This variant is also known as p.224_234dup10. ClinVar contains an entry for this variant (Variation ID: 4854). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 7, 2024